- Home
- ABCL
as of 12-18-2025 3:40pm EST
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
| Founded: | 2012 | Country: | Canada |
| Employees: | N/A | City: | VANCOUVER |
| Market Cap: | 1.1B | IPO Year: | 2020 |
| Target Price: | $7.75 | AVG Volume (30 days): | 3.6M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.58 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.89 - $6.51 | Next Earning Date: | 11-06-2025 |
| Revenue: | $35,325,000 | Revenue Growth: | 7.17% |
| Revenue Growth (this year): | 25.45% | Revenue Growth (next year): | 10.07% |
AI-Powered ABCL Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of AbCellera Biologics Inc. (ABCL)
Director
Avg Cost/Share
$3.57
Shares
50,000
Total Value
$178,460.00
Owned After
221,000
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Montalbano John S. | ABCL | Director | Nov 26, 2025 | Buy | $3.57 | 50,000 | $178,460.00 | 221,000 |
Compare ABCL vs Leading Stocks
See how ABCL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ABCL AbCellera Biologics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.